GovWire

Guidance: Adrenaline Auto-Injectors (AAIs) safety campaign

Medicines Healthcare Products Regulatory Agency

April 24
13:28 2023

The correct use of your Adrenaline Auto-Injector (AAI)

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Y defnydd cywir och Chwistrellydd Adrenalin Awtomatig (AAI)

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

AAIs (sometimes referred to by their product name i.e., Epipen or Emerade) are licensed medicinal products that deliver adrenaline by means of an auto-injector device for the emergency treatment of anaphylaxis, a life-threatening severe allergic reaction.

Published 24 April 2023

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: